A detailed history of Cozad Asset Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Cozad Asset Management Inc holds 18,656 shares of ABBV stock, worth $3.36 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
18,656
Previous 19,006 1.84%
Holding current value
$3.36 Million
Previous $3.26 Million 13.04%
% of portfolio
0.36%
Previous 0.33%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$163.84 - $199.33 $57,344 - $69,765
-350 Reduced 1.84%
18,656 $3.68 Million
Q2 2024

Aug 02, 2024

BUY
$154.79 - $180.76 $58,510 - $68,327
378 Added 2.03%
19,006 $3.26 Million
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $4,634 - $5,280
-29 Reduced 0.16%
18,628 $3.39 Million
Q4 2023

Feb 05, 2024

SELL
$137.6 - $154.97 $5,504 - $6,198
-40 Reduced 0.21%
18,657 $2.89 Million
Q3 2023

Nov 02, 2023

SELL
$133.59 - $154.65 $18,168 - $21,032
-136 Reduced 0.72%
18,697 $2.79 Million
Q2 2023

Jul 26, 2023

SELL
$132.51 - $164.9 $114,886 - $142,968
-867 Reduced 4.4%
18,833 $2.54 Million
Q1 2023

May 01, 2023

BUY
$144.61 - $166.54 $21,980 - $25,314
152 Added 0.78%
19,700 $3.14 Million
Q4 2022

Feb 07, 2023

BUY
$138.31 - $165.87 $183,813 - $220,441
1,329 Added 7.29%
19,548 $3.16 Million
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $159,575 - $183,022
-1,189 Reduced 6.13%
18,219 $2.45 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $20,505 - $26,069
-149 Reduced 0.76%
19,408 $2.97 Million
Q1 2022

Apr 29, 2022

BUY
$131.98 - $163.75 $354,630 - $439,996
2,687 Added 15.93%
19,557 $3.17 Million
Q4 2021

Feb 01, 2022

SELL
$107.43 - $135.93 $25,783 - $32,623
-240 Reduced 1.4%
16,870 $2.28 Million
Q3 2021

Nov 05, 2021

SELL
$106.4 - $120.78 $99,271 - $112,687
-933 Reduced 5.17%
17,110 $1.85 Million
Q2 2021

Jul 29, 2021

SELL
$105.21 - $117.21 $30,195 - $33,639
-287 Reduced 1.57%
18,043 $2.03 Million
Q1 2021

Apr 29, 2021

BUY
$102.3 - $112.62 $117,849 - $129,738
1,152 Added 6.71%
18,330 $1.98 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $5,875 - $7,932
-73 Reduced 0.42%
17,178 $1.84 Million
Q3 2020

Oct 28, 2020

BUY
$85.91 - $100.83 $14,346 - $16,838
167 Added 0.98%
17,251 $1.51 Million
Q2 2020

Aug 07, 2020

SELL
$73.37 - $98.18 $1.22 Million - $1.63 Million
-16,568 Closed
0 $0
Q1 2020

May 07, 2020

SELL
$64.5 - $97.79 $122,550 - $185,801
-1,900 Reduced 10.29%
16,568 $1.26 Million
Q4 2019

Jan 16, 2020

SELL
$72.13 - $90.25 $91,965 - $115,068
-1,275 Reduced 6.46%
18,468 $1.64 Million
Q3 2019

Oct 31, 2019

SELL
$62.98 - $75.72 $2.49 Million - $2.99 Million
-39,521 Reduced 66.69%
19,743 $1.5 Million
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $211,422 - $270,247
-3,218 Reduced 5.15%
59,264 $4.31 Million
Q1 2019

Apr 18, 2019

BUY
$77.14 - $90.79 $542,911 - $638,980
7,038 Added 12.69%
62,482 $5.04 Million
Q4 2018

Jan 14, 2019

SELL
$77.85 - $96.01 $968,843 - $1.19 Million
-12,445 Reduced 18.33%
55,444 $5.11 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $529,725 - $588,888
5,958 Added 9.62%
67,889 $6.42 Million
Q2 2018

Aug 15, 2018

BUY
$89.78 - $106.23 $5.56 Million - $6.58 Million
61,931 New
61,931 $5.74 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cozad Asset Management Inc Portfolio

Follow Cozad Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cozad Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cozad Asset Management Inc with notifications on news.